DeepMed IO is an ISO-13485 certified MedTech company based in the UK and Greece. Our mission is to utilize AI technology to enhance the accuracy and efficiency of diagnostic processes, ultimately providing personalized care solutions for patients and improving their quality of life. We collaborate closely with medical professionals to develop practical AI tools that can be utilized in clinical settings.

One of our most groundbreaking products is DeepPath™ – LYDIA, an AI-powered decision support system. This system, which has obtained a CE-Mark, aims to assist histopathologists in the cancer staging of patients with breast, lung, and colon cancer, as well as melanoma - accounting for 43% of total cancer cases. By accurately identifying metastatic regions on digitized microscope slides of H&E stained lymph nodes, DeepPath™ – LYDIA greatly expedites the diagnostic process while ensuring no tumor hotspots are missed.

At DeepMed IO, we are committed to leveraging technology to revolutionize the field of pathology and help healthcare professionals provide the best care possible. Learn more about our innovative solutions on our website